Calcitonin secretion in streak gonad syndrome (Turner's syndrome)

Janos Zseli, Peter Bosze, F. Szalay, Janos Szucs, C. Horváth, Eva Kollin, M. Szathmári, Janos Laszlo, Istvan Hollo

Research output: Article

10 Citations (Scopus)

Abstract

Osteoporosis in one of the most common complications of streak gonad syndrome (SGS), however, its pathogenesis is still unclear. To test whether SGS is associated with calcitonin (CT) deficiency, 11 affected individuals and 8 age-matched healthy women were studied. Calcium, 3.6 mg/kg b.w. as a 10% solution of calcium chloride, was given intravenously for 3 minutes. Serum levels of CT and calcium were measured before and at 5, 30, 60, and 120 minutes after the injection. There was a statistically significant rise in serum calcium levels both in the control subjects and patients with SGS, with significantly lower levels prior to and at 30, 60, and 120 minutes following calcium load in the control group. The CT rise following calcium load was also significant at 5, 30, and 60 minutes in the controls and at 5 and 30 minutes in patients with SGS, with a significantly lower baseline and 30, 60, and 120 minutes levels in the latter group. Maximum levels of calcium and CT occurred 5 minutes after the calcium load and were statistically indistinguishable. There were no significant differences in either the calcium or the CT incremental changes between the two groups. These findings are consistent with decreased basal (and 30-120 minute) CT levels in SGS and suggest that CT deficiency may be involved in the development of osteoporosis in patients with SGS. The possible causal relationship of estrogen deficiency to the reduced CT levels in SGS is discussed.

Original languageEnglish
Pages (from-to)297-299
Number of pages3
JournalCalcified Tissue International
Volume39
Issue number5
DOIs
Publication statusPublished - szept. 1986

Fingerprint

Turner Syndrome
Calcitonin
Gonads
Calcium
Osteoporosis
Calcium Chloride
Serum
Estrogens
Control Groups
Injections

ASJC Scopus subject areas

  • Endocrinology
  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Calcitonin secretion in streak gonad syndrome (Turner's syndrome). / Zseli, Janos; Bosze, Peter; Szalay, F.; Szucs, Janos; Horváth, C.; Kollin, Eva; Szathmári, M.; Laszlo, Janos; Hollo, Istvan.

In: Calcified Tissue International, Vol. 39, No. 5, 09.1986, p. 297-299.

Research output: Article

Zseli, Janos ; Bosze, Peter ; Szalay, F. ; Szucs, Janos ; Horváth, C. ; Kollin, Eva ; Szathmári, M. ; Laszlo, Janos ; Hollo, Istvan. / Calcitonin secretion in streak gonad syndrome (Turner's syndrome). In: Calcified Tissue International. 1986 ; Vol. 39, No. 5. pp. 297-299.
@article{a606777375ec4c67971acd9c2aa7cf8c,
title = "Calcitonin secretion in streak gonad syndrome (Turner's syndrome)",
abstract = "Osteoporosis in one of the most common complications of streak gonad syndrome (SGS), however, its pathogenesis is still unclear. To test whether SGS is associated with calcitonin (CT) deficiency, 11 affected individuals and 8 age-matched healthy women were studied. Calcium, 3.6 mg/kg b.w. as a 10{\%} solution of calcium chloride, was given intravenously for 3 minutes. Serum levels of CT and calcium were measured before and at 5, 30, 60, and 120 minutes after the injection. There was a statistically significant rise in serum calcium levels both in the control subjects and patients with SGS, with significantly lower levels prior to and at 30, 60, and 120 minutes following calcium load in the control group. The CT rise following calcium load was also significant at 5, 30, and 60 minutes in the controls and at 5 and 30 minutes in patients with SGS, with a significantly lower baseline and 30, 60, and 120 minutes levels in the latter group. Maximum levels of calcium and CT occurred 5 minutes after the calcium load and were statistically indistinguishable. There were no significant differences in either the calcium or the CT incremental changes between the two groups. These findings are consistent with decreased basal (and 30-120 minute) CT levels in SGS and suggest that CT deficiency may be involved in the development of osteoporosis in patients with SGS. The possible causal relationship of estrogen deficiency to the reduced CT levels in SGS is discussed.",
keywords = "Calcitonin deficiency, I. V. calcium load, Osteoporosis, Streak gonad syndrome",
author = "Janos Zseli and Peter Bosze and F. Szalay and Janos Szucs and C. Horv{\'a}th and Eva Kollin and M. Szathm{\'a}ri and Janos Laszlo and Istvan Hollo",
year = "1986",
month = "9",
doi = "10.1007/BF02555193",
language = "English",
volume = "39",
pages = "297--299",
journal = "Calcified Tissue International",
issn = "0171-967X",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Calcitonin secretion in streak gonad syndrome (Turner's syndrome)

AU - Zseli, Janos

AU - Bosze, Peter

AU - Szalay, F.

AU - Szucs, Janos

AU - Horváth, C.

AU - Kollin, Eva

AU - Szathmári, M.

AU - Laszlo, Janos

AU - Hollo, Istvan

PY - 1986/9

Y1 - 1986/9

N2 - Osteoporosis in one of the most common complications of streak gonad syndrome (SGS), however, its pathogenesis is still unclear. To test whether SGS is associated with calcitonin (CT) deficiency, 11 affected individuals and 8 age-matched healthy women were studied. Calcium, 3.6 mg/kg b.w. as a 10% solution of calcium chloride, was given intravenously for 3 minutes. Serum levels of CT and calcium were measured before and at 5, 30, 60, and 120 minutes after the injection. There was a statistically significant rise in serum calcium levels both in the control subjects and patients with SGS, with significantly lower levels prior to and at 30, 60, and 120 minutes following calcium load in the control group. The CT rise following calcium load was also significant at 5, 30, and 60 minutes in the controls and at 5 and 30 minutes in patients with SGS, with a significantly lower baseline and 30, 60, and 120 minutes levels in the latter group. Maximum levels of calcium and CT occurred 5 minutes after the calcium load and were statistically indistinguishable. There were no significant differences in either the calcium or the CT incremental changes between the two groups. These findings are consistent with decreased basal (and 30-120 minute) CT levels in SGS and suggest that CT deficiency may be involved in the development of osteoporosis in patients with SGS. The possible causal relationship of estrogen deficiency to the reduced CT levels in SGS is discussed.

AB - Osteoporosis in one of the most common complications of streak gonad syndrome (SGS), however, its pathogenesis is still unclear. To test whether SGS is associated with calcitonin (CT) deficiency, 11 affected individuals and 8 age-matched healthy women were studied. Calcium, 3.6 mg/kg b.w. as a 10% solution of calcium chloride, was given intravenously for 3 minutes. Serum levels of CT and calcium were measured before and at 5, 30, 60, and 120 minutes after the injection. There was a statistically significant rise in serum calcium levels both in the control subjects and patients with SGS, with significantly lower levels prior to and at 30, 60, and 120 minutes following calcium load in the control group. The CT rise following calcium load was also significant at 5, 30, and 60 minutes in the controls and at 5 and 30 minutes in patients with SGS, with a significantly lower baseline and 30, 60, and 120 minutes levels in the latter group. Maximum levels of calcium and CT occurred 5 minutes after the calcium load and were statistically indistinguishable. There were no significant differences in either the calcium or the CT incremental changes between the two groups. These findings are consistent with decreased basal (and 30-120 minute) CT levels in SGS and suggest that CT deficiency may be involved in the development of osteoporosis in patients with SGS. The possible causal relationship of estrogen deficiency to the reduced CT levels in SGS is discussed.

KW - Calcitonin deficiency

KW - I. V. calcium load

KW - Osteoporosis

KW - Streak gonad syndrome

UR - http://www.scopus.com/inward/record.url?scp=0022499669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022499669&partnerID=8YFLogxK

U2 - 10.1007/BF02555193

DO - 10.1007/BF02555193

M3 - Article

C2 - 3102018

AN - SCOPUS:0022499669

VL - 39

SP - 297

EP - 299

JO - Calcified Tissue International

JF - Calcified Tissue International

SN - 0171-967X

IS - 5

ER -